This activity is designed for pharmacists and other health care professionals interested in expanding Overdose Education and Naloxone Distribution (OEND) at their practice site.
Session Summary
Prescription drug and opioid overdoses continue to rise in the U.S. Communities with Overdose Education and Naloxone Distribution (OEND) programs have demonstrated how effective this practice can be in the number of lives reported to have been saved. Legislation to allow access to naloxone for non-medical people has also been passed by many states. Since naloxone remains a prescription medication, pharmacists have an important role in facilitating access to this potentially life-saving medication. Many pharmacists are already incorporating OEND into their practice, but opportunities for expanding OEND practice remain. Expert presenters will present the various models they have implemented to increase Naloxone distribution within their practice setting.
Course Requirements
You will proceed through the following steps to satisfactorily complete this course:
Sign in (or create a FREE account).
Register for this course.
Review the full content of the activity and reflect upon its teachings.
Complete the evaluation after participating/viewing the webinar.
Complete the post-test at the end of the activity no later than the closing activity date.
If necessary, complete the post-test retest no later than the closing activity date.
Receive a passing grade (70%).
Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor.
This course is provided online at cpnp.org and consists of the speaker audio and slides. A PDF file of the slides is also provided and access is available to participants indefinitely although ACPE credit is available only through the course expiration date.
Participants in this course must complete an examination and achieve a score of 70% or greater. Successful completion of the course also requires the completion of a course evaluation. ACPE statements of credit can be retrieved by participants online at cpnp.org immediately upon successful completion of the course.
CPNP has invested in supporting the most popular web browsers and leveraging software that our members use daily. Beyond PDF downloads, the rest of the system is built on HTML5, a technology that most up-to-date browsers will support. To access CPNP course materials online, you will need:
A modern web browser with JavaScript and cookies enabled: Chrome is strongly recommended,
but most features work with Internet Explorer 10+, or the latest version of Firefox or Safari.
A PDF reader: Chrome built-in, Firefox built-in, Acrobat or FoxIt
CPNP web sites no longer fully support Microsoft Internet Explorer 9 and older or Windows 7 and older. We cannot guarantee that the site will function perfectly on every device and configuration, but using the latest version of the software above will greatly improve your experience.
Jeffrey Bratberg, PharmD, BCPS
Clinical Professor of Pharmacy Practice
University of Rhode Island College of Pharmacy
Kingston, RI
Dr. Bratberg's research interests include expanding pharmacists’ roles in public health, particularly in emergency preparedness, disease surveillance, prevention of opioid drug overdose and death, and expansion of immunization practice. He currently helps implement the Rhode Island Collaborative Pharmacy Practice Agreement for naloxone (CPAN), an effort including the RI Department of Health, RI Board of Pharmacy, and nearly every Rhode Island Walgreens and CVS pharmacy, totaling 88 pharmacies and almost 400 pharmacists. He has worked on quantitative and qualitative studies on the use of pharmacists and pharmacies in public health initiatives, particularly as an expert consultant on a grant examining methods of connecting HIV positive patients with substance use disorders to pharmacies that furnish naloxone across the country. As former president of the Rhode Island Pharmacists Association (RIPA), Dr. Bratberg is also well acquainted with the challenges facing community pharmacists and pharmacies regarding opioid dispensing, opioid safety, overdose, and addiction.
James Gasper, PharmD, BCPP
Psychiatric and Substance Use Disorder Pharmacist
California Department of Health Care Services
Sacramento, CA
Dr. Gasper received his undergraduate degree from University of Denver and Doctor of Pharmacy from the University of Colorado. He completed a pharmacy practice residency at the Denver Veterans Affairs Medical Center and a specialty residency in psychiatric pharmacy at UCSF.
Dr. Gasper’s current position is as a psychiatric and substance use disorder pharmacist for the California Department of Health Care Services. His present initiatives include expanding access to medication assisted treatment for substance use disorders, promoting naloxone access, and improving safe prescribing of opioid analgesics. Before coming to the Department last year he served for the last decade as a psychiatric clinical pharmacist for San Francisco County’s Community Behavioral Health Program which cares for indigent patients with mental illness and substance use disorders.
In addition to his clinical and policy work Dr. Gasper has been an investigator on several NIH sponsored research grants. These include the use of naloxone for opioid safety, smoking cessation in opioid dependence treatment, and the pharmacological management of methamphetamine addiction.
Theodore Pikoulas, PharmD, BCPP
Associate Director of Behavioral Health Pharmacy Programs
Community Care of North Carolina
Raleigh, NC
Dr. Pikoulas is Psychiatric Pharmacy Specialist and is currently the Associate Director of Behavioral Health Pharmacy Programs for Community Care of North Carolina (CCNC), a state-wide care management entity for North Carolina Medicaid Beneficiaries. He received his Doctor of Pharmacy degree from the Mylan School of Pharmacy at Duquesne University in Pittsburgh, PA. He went on to complete a Pharmacy Practice Residency at the University of Pittsburgh Medical Center Mercy Hospital in Pittsburgh, PA, and a Psychiatric Pharmacy Residency at the Louis Stokes Cleveland VA Medical Center in Cleveland, OH. In his role, Dr. Pikoulas works with both the pharmacy team and the behavioral health team to assist in the implementation and ongoing operation of behavioral health pharmacy projects. He is also an active member of the College of Psychiatric and Neurologic Pharmacists where he serves on the Substance Abuse Task Force.
Dr. Saldana received her Doctor of Pharmacy from Purdue University in 2003 and Master of Science from The University of Texas at Austin in 2005. She completed a specialty residency in psychiatry in 2005 and obtained board certification as a psychiatric pharmacist later that year. Dr. Saldanda has worked as a clinical pharmacist in psychiatry since 2005 in large hospitals and healthcare systems, each with levels of care spanning inpatient, residential, partial hospitalization, outpatient, and chemical dependency.
Shannon is a member of the Intermountain Healthcare Behavioral Health Clinical Program (BHCP) Guidance Council and the Substance Use Disorder subcommittee. She was the lead author of the medication sections of the Substance Use Disorder Care Process Model approved by the BHCP Guidance Council in November 2014. She is Co-Chair of the Intermountain Partnership in the Utah Pharmaceutical Drug Community Project (UPDCP), aimed at reducing death from prescription pain medication overdose. Within this role, she serves on the Use Only As Directed Campaign, in which the largest endeavor is the Intermountain Pharmacy Services Drug Take-Back Program. As well, she is a member of the UPDCP naloxone working group to develop educational information and increase access in the community. Shannon also represents Intermountain Healthcare in the Utah-wide collaborative to increase overdose education and naloxone distribution (OEND). She co-leads efforts to implement the availability of intranasal and intramuscular naloxone kits in Intermountain Community Pharmacies, which became available in February 2015.
Christopher Stock, PharmD, BCPP
Clinical Pharmacy Specialist, Substance Use Disorder Program
George E Wahlen VA Medical Center
Adjunct Professor, Pharmacotherapy
University of Utah
Salt Lake City, UT
Chris Stock, PharmD, BCPP is a clinical pharmacy specialist for the substance abuse treatment programs at the George E Wahlen VA Medical Center in Salt Lake City and Adjunct Professor at the University of Utah. He ran the VA’s outpatient detoxification clinic for alcohol and opioids for nearly 15. He co-chairs the opioid safety committee at the VA. He is an active clinical investigator, has partnered with NIDA (the National Institutes on Drug Abuse) and the VA research office for the past 20 years conducting studies on Medication Assisted Treatments for Opiate, Alcohol, Tobacco, Methamphetamine and Cocaine Addiction. He spearheaded the pharmacist managed overdose education and naloxone distribution (OEND) program at the Salt Lake City VA, works with the VA’s national OEND committee and has worked tirelessly throughout Utah advocating for naloxone access legislation in 2014 and aiding pharmacist to incorporate OEND in their practices.
Faculty Disclosures
Presentation will include discussion of off-label, experimental, and/or investigational use of drugs or devices: Presentation will include discussion of off-label, experimental, and/or investigational use of drugs or devices: Naloxone IV used for intranasal administration (off-label)
All relevant relationships have been mitigated.
Learning Objectives
Identify a model for overdose education and naloxone distribution (OEND) that is most applicable to their practice setting.
Summarize patient overdose education (OE) elements that will fit best in their practice setting.
Describe strategies to bill an insurance carrier for OEND in their practice setting.
Describe strategies to overcome some of the barriers to developing OEND in their practice setting.
Continuing Education Credit and Disclosures
Webinar Date: The live webinar has already finished Activity Dates:08/13/2015 - 08/13/2016 ACPE Contact Hours: 1 ACPE Number: 0284-0000-15-078-H04-P (Knowledge) Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.
The College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This self-study course provides 1.0 contact hours (0.01 CEUs) of knowledge-based continuing education credit from CPNP approved programming. The ACPE universal program number assigned to this course is 0284-0000-15-078-H04-P (1.0 contact hours).
Off-Label Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA (see faculty information and disclosures). The opinions expressed in the educational activity do not necessarily represent the views of CPNP and any educational partners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Presentation-Specific Disclosure: Presentation will include discussion of off-label, experimental, and/or investigational use of drugs or devices: Naloxone IV used for intranasal administration (off-label)
It is the policy of CPNP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by CPNP for any product or manufacturer identified.
Grant Support
This activity is supported by the American Academy of Addiction Psychiatry under its prime grant from the Substance Abuse and Mental Health Services Administration. Funding for this initiative was made possible (in part) by Providers’ Clinical Support System for Opioid Therapies (grant no. 1H79TI025595) from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
AAPP websites use cookies to personalize and enhance your experience.
By continuing to use the site, you agree to this collection.
Learn more.
The College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This self-study course provides 1.0 contact hours (0.01 CEUs) of knowledge-based continuing education credit from CPNP approved programming. The ACPE universal program number assigned to this course is 0284-0000-15-078-H04-P (1.0 contact hours).